Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mohammad Shehab

Showing results (11-20 of 64) with videos related to

Pageof 7
Sort By:
Healthcare (Basel, Switzerland)|October 27, 2022
The Role of Clinical Pharmacists in Improving Quality of Care in Patients with Inflammatory Bowel Disease: An Evaluation of Patients' and Physicians' SatisfactionFatema Alrashed, Najlaa Almutairi, Mohammad Shehab
Diseases (Basel, Switzerland)|November 22, 2022
Effectiveness of Dual Biologic or Small Molecule Therapy for Achieving Endoscopic Remission in Refractory Inflammatory Bowel DiseaseIsraa Abdullah, Khaled AlMojil, Mohammad Shehab
Vaccines|July 27, 2022
COVID-19 Vaccine Booster Dose Willingness among Patients with Inflammatory Bowel Disease on Infliximab and Vedolizumab: A Cross-Sectional StudyMohammad Shehab, Fatema Alrashed, Ahmad Alfadhli
Alimentary Pharmacology & Therapeutics|February 25, 2025
Editorial: Surveillance Colonoscopy for Detection of Neoplasia in Inflammatory Bowel Disease-Is Dye-Based Chromoendoscopy Always the Final Answer? Authors' ReplyMohammad Shehab, Ahmed Al-Hindawi, Talat Bessissow
Case Reports in Gastroenterology|August 29, 2025
Vancomycin for the Induction and Maintenance of Remission in Biologics Refractory Patient with Ulcerative Colitis and Primary Sclerosing Cholangitis Post-Liver and Bone Marrow TransplantationMohammad Shehab, Anwar Almajdi, Mohammed Alotaibi, et al.
Medicine|July 5, 2024
Relationship between Ustekinumab trough concentrations and clinical, biochemical and endoscopic outcomes in Crohn's disease: A multi-center nationwide retrospective study (TARGET STUDY)Mohammad Shehab, Israa Abdullah, Ahmad Alfadhli, et al.
Journal of the Canadian Association of Gastroenterology|December 5, 2022
Biologic Therapies for the Treatment of Post-ileal Pouch Anal Anastomosis Surgery Chronic Inflammatory Disorders: Systematic Review and Meta-analysisMohammad Shehab, Fatema Alrashed, Aline Charabaty, et al.
Infection Prevention in Practice|July 28, 2021
Effectiveness of inspectors' team in increasing compliance with personal protective equipment use and reducing COVID19 infection spread among healthcare workersMohammad Shehab, Sameera Shuaibi, Iman Qadhi, et al.
Frontiers in Pharmacology|October 25, 2023
Effectiveness of vedolizumab and ustekinumab as second biologic agent in achieving target outcomes in tumor necrosis factor antagonists experienced patients with inflammatory bowel disease (enroll-ex study)Fatema Alrashed, Israa Abdullah, Ahmad Alfadhli, et al.
Journal of Clinical Medicine|December 30, 2025
Safety and Effectiveness of Multi-Switch Between Adalimumab Originator and Biosimilars: A Multicenter (SUSTAIN) StudyMohammad Shehab, Anwar Almajdi, Israa Abdullah, et al.
Pageof 7

Showing results (11-20 of 64) with videos related to

Sort By:
Pageof 7
Healthcare (Basel, Switzerland)|October 27, 2022
The Role of Clinical Pharmacists in Improving Quality of Care in Patients with Inflammatory Bowel Disease: An Evaluation of Patients' and Physicians' SatisfactionFatema Alrashed, Najlaa Almutairi, Mohammad Shehab
Diseases (Basel, Switzerland)|November 22, 2022
Effectiveness of Dual Biologic or Small Molecule Therapy for Achieving Endoscopic Remission in Refractory Inflammatory Bowel DiseaseIsraa Abdullah, Khaled AlMojil, Mohammad Shehab
Vaccines|July 27, 2022
COVID-19 Vaccine Booster Dose Willingness among Patients with Inflammatory Bowel Disease on Infliximab and Vedolizumab: A Cross-Sectional StudyMohammad Shehab, Fatema Alrashed, Ahmad Alfadhli
Alimentary Pharmacology & Therapeutics|February 25, 2025
Editorial: Surveillance Colonoscopy for Detection of Neoplasia in Inflammatory Bowel Disease-Is Dye-Based Chromoendoscopy Always the Final Answer? Authors' ReplyMohammad Shehab, Ahmed Al-Hindawi, Talat Bessissow
Case Reports in Gastroenterology|August 29, 2025
Vancomycin for the Induction and Maintenance of Remission in Biologics Refractory Patient with Ulcerative Colitis and Primary Sclerosing Cholangitis Post-Liver and Bone Marrow TransplantationMohammad Shehab, Anwar Almajdi, Mohammed Alotaibi, et al.
Medicine|July 5, 2024
Relationship between Ustekinumab trough concentrations and clinical, biochemical and endoscopic outcomes in Crohn's disease: A multi-center nationwide retrospective study (TARGET STUDY)Mohammad Shehab, Israa Abdullah, Ahmad Alfadhli, et al.
Journal of the Canadian Association of Gastroenterology|December 5, 2022
Biologic Therapies for the Treatment of Post-ileal Pouch Anal Anastomosis Surgery Chronic Inflammatory Disorders: Systematic Review and Meta-analysisMohammad Shehab, Fatema Alrashed, Aline Charabaty, et al.
Infection Prevention in Practice|July 28, 2021
Effectiveness of inspectors' team in increasing compliance with personal protective equipment use and reducing COVID19 infection spread among healthcare workersMohammad Shehab, Sameera Shuaibi, Iman Qadhi, et al.
Frontiers in Pharmacology|October 25, 2023
Effectiveness of vedolizumab and ustekinumab as second biologic agent in achieving target outcomes in tumor necrosis factor antagonists experienced patients with inflammatory bowel disease (enroll-ex study)Fatema Alrashed, Israa Abdullah, Ahmad Alfadhli, et al.
Journal of Clinical Medicine|December 30, 2025
Safety and Effectiveness of Multi-Switch Between Adalimumab Originator and Biosimilars: A Multicenter (SUSTAIN) StudyMohammad Shehab, Anwar Almajdi, Israa Abdullah, et al.
Pageof 7